Immuron (IMRN) EBITDA (2016 - 2024)

Immuron (IMRN) recorded quarterly EBITDA of $1660259127.7 billion in Q4 2024, up 80254566798273.6% quarter-over-quarter from $2.1 million in Q4 2023, and up 80254566798273.6% on a YoY basis from N/an in Q1 2024.

Immuron (IMRN) EBITDA (2016 - 2024) Analysis & Trends

Immuron's EBITDA history runs 9 years deep, the most recent figure standing at $1660259127.7 billion for Q4 2024.

  • In Q4 2024, EBITDA rose 80254566798273.6% year-over-year to $1660259127.7 billion; the TTM figure through Dec 2024 stood at $1660259127.7 billion (up 59404062924833.59% YoY), while the FY2025 annual figure was -$3.4 million, up 9.08% from the prior year.
  • EBITDA was $1660259127.7 billion for Q4 2024 at Immuron, up from $2.1 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $1660259127.7 billion in Q4 2024 to a low of -$1.2 million in Q2 2023.
  • Historically, EBITDA has averaged $237179875.4 billion across 5 years, with a median of $2.0 million in 2022.
  • The sharpest annual moves came in 2020 and 2024: EBITDA plunged 272.4% in 2020, then soared 80254566798273.6% in 2024.
  • A 5-year view of EBITDA shows it stood at -$57538.3 in 2020, then surged by 76.96% to -$13256.7 in 2021, then jumped by 15029.93% to $2.0 million in 2022, then gained by 4.52% to $2.1 million in 2023, then jumped by 80254566798273.6% to $1660259127.7 billion in 2024.
  • The last three EBITDA figures came in at $1660259127.7 billion (Q4 2024), $2.1 million (Q4 2023), and $2.4 million (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.92 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -13.63 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -19.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.82 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.44 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -752,618.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.14 Bn
9 Abivax 91.96 Bn 91.96 Bn - -65.83 Mn
10 Immuron 921.61 Mn 921.58 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 1,660,259,127.73 Bn
Dec 31, 2023 2.07 Mn
Sep 28, 2023 2.43 Mn
Jun 30, 2023 -1.24 Mn
Dec 31, 2022 1.98 Mn
Dec 31, 2021 -13,256.74
Dec 31, 2020 -57,538.29
Dec 31, 2019 -15,450.84
Dec 31, 2018 1.69 Mn
Dec 31, 2017 -1.45 Mn
Dec 31, 2016 -2.60 Mn
Jun 30, 2016 -3.28 Mn